Staging von Kopf-Hals-Tumoren mit bildgebenden Verfahren

Zusammenfassung

Das Staging maligner Tumoren dient hauptsächlich der stadiengerechten Auswahl einer angemessenen Therapie. Bei Kopf-Hals-Tumoren spielen - neben der klinischen Untersuchung und Endoskopie - dabei insbesondere die modernen Schnittbildverfahren eine entscheidende Rolle.

Der vorliegende II. Teil dieses Artikels soll den Stellenwert der Schnittbilddiagnostik zum N- und M-Staging maligner Kopf-Hals-Tumoren illustrieren und aufzeigen, wie die Therapieauswahl durch den radiologischen Befund gesteuert wird. Leitlinien zur Durchführung der Untersuchung und zu wichtigen Details der Befundung können daraus abgeleitet werden.

Abstract

Staging of malignant tumours is predominantly addressed to facilitate selection of the appropriate treatment. Adjacent to physical examination and endoscopy, modern crossectional imaging plays a crucial role in the head and neck region.

The second part of this article efforts to illustrate the value of crossectional imaging in N- and M-staging of head and neck tumours and to highlight, how treatment selection is influenced by radiological findings. Guidelines to perform and evaluate the examination are presented.

Head neck region - cancer staging - carcinoma - larynx - pharynx - oropharynx - nasopharynx - hypopharynx - oral - nasal - maxillary - maxillar - sphenoidal - ethmoidal - ethmoid cell - frontal sinus cavity - parotid - thyroid - supraglottic - infraglottic - glottic - malignant salivary gland tumor - tumour - MRI - CT - PET - magnetic resonance - crossectional treatment selection - imaging procedures · computer tomography - USPIO - t-staging - n-staging - m-staging - nodal - distant metastasis - AJCC - UICC

Kernaussagen

N-Staging

Bedeutung. Der Lymphknotenstatus beeinflusst sowohl die Primärtherapie als auch die Prognose. Die Einteilung der zervikalen Lymphknoten in 7 Lymphknotenlevel dient unter anderem dazu, die Art der Neck Dissection (selektiv oder radikal) festzulegen. Die Klassifikation des Lymphknotenstatus ist für alle Kopf-Hals-Tumoren einheitlich - ausgenommen Schilddrüsentumoren und Nasopharynxkarzinome.

Bildgebung. Die Sonographie des Halses ist die Standardmethode zum Lymphknotenstaging maligner Kopf-Hals-Tumoren. Kriterien zur Unterscheidung zwischen benigne und maligne sind kugelige Umwandlung, Echogenität, Lymphknotenform und -größe, Gruppierung und zentrale Nekrose. Möglicherweise wird in Zukunft die USPIO-verstärkte MRT an Bedeutung zunehmen.

M-Staging

Für alle Tumoren werden die Stadien M0 (keine Fernmetastasen) und M1 (Fernmetastasen vorhanden) unterschieden. Ein M1-Staging bedeutet für alle Kopf-Hals-Tumoren ein klinisches Stadium IVc, die schlechteste Prognosegruppe und in der Regel eine palliative Therapie. Bei nahezu allen Patienten mit Fernmetastasen liegen auch Metastasen in der Lunge vor, die mit Abstand der häufigste Ort einer Fernmetastasierung bei Plattenepithelkarzinomen der Kopf-Hals-Region ist.

Literatur

• 1 Greene F L. (Hrsg) .Cancer Staging Handbook: TNM Classification of Malignant Tumors. Heidelberg; Springer 2002
• 2 Chung N N, Ting L L, Hsu W C, Lui L T, Wang P M. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy.  Head Neck. 2004;  26 241-246
• 3 Chang J T, Lin C Y, Chen T M. et al . Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.  Int J Radiat Oncol Biol Phys. 2005;  63 1354-1360
• 4 Yen T C, Lin C Y, Wang H M. et al . 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma.  Int J Radiat Oncol Biol Phys. 2006;  65 1307-1314
• 5 Lau K Y, Kan W K, Sze W M. et al . Magnetic Resonance for T-staging of nasopharyngeal carcinoma-the most informative pair of sequences.  Jpn J Clin Oncol. 2004;  34 171-175
• 6 King A D, Lam W W, Leung S F, Chan Y L, Teo P, Metreweli C. MRI of local disease in nasopharyngeal carcinoma: tumour extent vs tumour stage.  Br J Radiol. 1999;  72 734-741
• 7 Olmi P, Fallai C, Colagrande S, Giannardi G. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography.  Int J Radiat Oncol Biol Phys. 1995;  32 795-800
• 8 Sakata K, Hareyama M, Tamakawa M. et al . Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging.  Int J Radiat Oncol Biol Phys. 1999;  43 273-278
• 9 Ma X, Lu J J, Loh K S, Shakespeare T P, Thiagarajan A, Goh B C, Tan K S. Role of computed tomography imaging in predicting response of nasopharyngeal carcinoma to definitive radiation therapy.  Laryngoscope. 2006;  116 2162-2165
• 10 Mukherji S K, Schmalfuss I M, Castelijns J, Mancuso A A. Clinical applications of tumor volume measurements for predicting outcome in patients with squamous cell carcinoma of the upper aerodigestive tract.  AJNR Am J Neuroradiol. 2004;  25 1425-1432
• 11 Sze W M, Lee A W, Yau T K. et al . Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.  Int J Radiat Oncol Biol Phys. 2004;  59 21-27
• 12 Chong V F, Zhou J Y, Khoo J B, Chan K L, Huang J. Correlation between MR imaging-derived nasopharyngeal carcinoma tumor volume and TNM system.  Int J Radiat Oncol Biol Phys. 2006;  64 72-76
• 13 Hsu W C, Loevner L A, Karpati R. et al . Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancer to the prevertebral space.  Head Neck. 2005;  27 95-100
• 14 Righi P D, Kelley D J, Ernst R, Deutsch M D, Gaskill-Shipley M, Wilson K M, Gluckman J L. Evaluation of prevertebral muscle invasion by squamous cell carcinoma. Can computed tomography replace open neck exploration?.  Arch Otolaryngol Head Neck Surg. 1996;  122 660-663
• 15 Hermans R. Staging of laryngeal and hypopharyngeal cancer: value of imaging studies.  Eur Radiol. 2006;  16 2386-2400
• 16 Batsakis J G. (Hrsg) .Tumors of the Head and Neck: Clinical and Pathological Considerations. Lippincott William & Wilkins 1979
• 17 Som P M, Curtin H D. (Hrsg) .Head and Neck Imaging. St. Louis; Mosby 2003
• 18 Mukherji S K, Pillsbury H R, Castillo M. Imaging squamous cell carcinomas of the upper aerodigestive tract: what clinicians need to know.  Radiology. 1997;  205 629-646
• 19 Mukherji S K, Weeks S M, Castillo M, Yankaskas B C, Krishnan L A, Schiro S. Squamous cell carcinomas that arise in the oral cavity and tongue base: can CT help predict perineural or vascular invasion?.  Radiology. 1996;  198 157-162
• 20 McGregor A D, MacDonald D G. Routes of entry of squamous cell carcinoma to the mandible.  Head Neck Surg. 1988;  10 294-301
• 21 Dammann F, Horger M, Mueller-Berg M. et al . Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET.  AJR Am J Roentgenol. 2005;  184 1326-1331
• 22 Weber A L, Romo L, Hashmi S. Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation.  Neuroimaging Clin N Am. 2003;  13 443-464
• 23 Bolzoni A, Cappiello J, Piazza C, Peretti G, Maroldi R, Farina D, Nicolai P. Diagnostic accuracy of magnetic resonance imaging in the assessment of mandibular involvement in oral-oropharyngeal squamous cell carcinoma: a prospective study.  Arch Otolaryngol Head Neck Surg. 2004;  130 837-843
• 24 Imaizumi A, Yoshino N, Yamada I. et al . A potential pitfall of MR imaging for assessing mandibular invasion of squamous cell carcinoma in the oral cavity.  AJNR Am J Neuroradiol. 2006;  27 114-122
• 25 Mukherji S K, Isaacs D L, Creager A, Shockley W, Weissler M, Armao D. CT detection of mandibular invasion by squamous cell carcinoma of the oral cavity.  AJR Am J Roentgenol. 2001;  177 237-243
• 26 Weissman J L, Carrau R L. „Puffed-cheek” CT improves evaluation of the oral cavity.  AJNR Am J Neuroradiol. 2001;  22 741-744
• 27 Schaefer S D, Maravilla K R, Suss R A, Burns D K, Nunnally R, Merkel M A, Close L G. Magnetic resonance imaging vs computed tomography. Comparison in imaging oral cavity and pharyngeal carcinomas.  Arch Otolaryngol. 1985;  111 730-734
• 28 Po Wing Y A, Lam K Y, Lam L K. et al . Prognostic factors of clinically stage I and II oral tongue carcinoma - A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features.  Head Neck. 2002;  24 513-520
• 29 Yuen A P, Lam K Y, Wei W I, Lam K Y, Ho C M, Chow T L, Yuen W F. A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma.  Am J Surg. 2000;  180 139-143
• 30 Lam P, Au-Yeung K M, Cheng P W. et al . Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer.  AJR Am J Roentgenol. 2004;  182 803-808
• 31 Preda L, Chiesa F, Calabrese L. et al . Relationship between histologic thickness of tongue carcinoma and thickness estimated from preoperative MRI.  Eur Radiol. 2006;  16 2242-2248
• 32 Close L G, Brown P M, Vuitch M F, Reisch J, Schaefer S D. Microvascular invasion and survival in cancer of the oral cavity and oropharynx.  Arch Otolaryngol Head Neck Surg. 1989;  115 1304-1309
• 33 Million R R, Cassisi N J, Mancuso A A. Hypopharynx: Pharyngeal walls, pyriform sinus, postcricoid pharynx. In: Million RR, Cassisi NJ (Hrsg) Management of head and neck cancer: a multidisciplinary approach. Philadelphia; Lippincott 1994: 505-532
• 34 Rumboldt Z, Gordon L, Gordon L, Bonsall R, Ackermann S. Imaging in head and neck cancer.  Curr Treat Options Oncol. 2006;  7 23-34
• 35 Keberle M, Kenn W, Hahn D. Current concepts in imaging of laryngeal and hypopharyngeal cancer.  Eur Radiol. 2002;  12 1672-1683
• 36 Lell M M, Greess H, Hothorn T, Janka R, Bautz W A, Baum U. Multiplanar functional imaging of the larynx and hypopharynx with multislice spiral CT.  Eur Radiol. 2004;  14 2198-2205
• 37 Stadler A, Kontrus M, Kornfehl J, Youssefzadeh S, Bankier A A. Tumor staging of laryngeal and hypopharyngeal carcinomas with functional spiral CT: comparison with nonfunctional CT, histopathology, and microlaryngoscopy.  J Comput Assist Tomogr. 2002;  26 279-284
• 38 Hermans R, Pameijer F A, Mancuso A A, Parsons J T, Mendenhall W M. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?.  Radiology. 2000;  214 683-687
• 39 Maroldi R, Battaglia G, Nicolai P. et al . CT appearance of the larynx after conservative and radical surgery for carcinomas.  Eur Radiol. 1997;  7 418-431
• 40 Mukherji S K, Mancuso A A, Kotzur I M. et al . Radiologic appearance of the irradiated larynx. Part II. Primary site response.  Radiology. 1994;  193 149-154
• 41 Mukherji S K, Mancuso A A, Kotzur I M. et al . Radiologic appearance of the irradiated larynx. Part I. Expected changes.  Radiology. 1994;  193 141-148
• 42 Becker M. Neoplastic invasion of laryngeal cartilage: radiologic diagnosis and therapeutic implications.  Eur J Radiol. 2000;  33 216-229
• 43 Atula T, Markkola A, Leivo I, Makitie A. Cartilage invasion of laryngeal cancer detected by magnetic resonance imaging.  Eur Arch Otorhinolaryngol. 2001;  258 272-275
• 44 Becker M, Zbaren P, Laeng H, Stoupis C, Porcellini B, Vock P. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation.  Radiology. 1995;  194 661-669
• 45 Chen S W, Yang S N, Liang J A, Tsai M H, Shiau A C, Lin F J. Value of computed tomography-based tumor volume as a predictor of outcomes in hypopharyngeal cancer after treatment with definitive radiotherapy.  Laryngoscope. 2006;  116 2012-2017
• 46 Becker M. Larynx and hypopharynx.  Radiol Clin North Am. 1998;  36 891-920
• 47 Castelijns J A, Becker M, Hermans R. Impact of cartilage invasion on treatment and prognosis of laryngeal cancer.  Eur Radiol. 1996;  6 156-169
• 48 Becker M, Zbaren P, Delavelle J, Kurt A M, Egger C, Rufenacht D A, Terrier F. Neoplastic invasion of the laryngeal cartilage: reassessment of criteria for diagnosis at CT.  Radiology. 1997;  203 521-532
• 49 Ljumanovic R, Langendijk J A, Schenk B, van Wattingen M, Knol D L, Leemans C R, Castelijns J A. Supraglottic carcinoma treated with curative radiation therapy: identification of prognostic groups with MR imaging.  Radiology. 2004;  232 440-448
• 50 Mancuso A A, Mukherji S K, Schmalfuss I. et al . Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma.  J Clin Oncol. 1999;  17 631-637
• 51 Murakami R, Furusawa M, Baba Y. et al . Dynamic helical CT of T1 and T2 glottic carcinomas: predictive value for local control with radiation therapy.  AJNR Am J Neuroradiol. 2000;  21 1320-1326
• 52 Kresnik E, Mikosch P, Gallowitsch H J. et al . Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.  Eur J Nucl Med. 2001;  28 816-821
• 53 Gordin A, Daitzchman M, Doweck I. et al . Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.  Laryngoscope. 2006;  116 273-278
• 54 Ross D S. Nonpalpable thyroid nodules - managing an epidemic.  J Clin Endocrinol Metab. 2002;  87 1938-1940
• 55 Marqusee E, Benson C B, Frates M C, Doubilet P M, Larsen P R, Cibas E S, Mandel S J. Usefulness of ultrasonography in the management of nodular thyroid disease.  Ann Intern Med. 2000;  133 696-700
• 56 Kim E K, Park C S, Chung W Y, Oh K K, Kim D I, Lee J T, Yoo H S. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid.  AJR Am J Roentgenol. 2002;  178 687-691
• 57 Pacini F, Burroni L, Ciuoli C, di Cairano G, Guarino E. Management of thyroid nodules: a clinicopathological, evidence-based approach.  Eur J Nucl Med Mol Imaging. 2004;  31 1443-1449
• 58 Pacini F, Schlumberger M, Dralle H, Elisei R, Smit J W, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.  Eur J Endocrinol. 2006;  154 787-803
• 59 Iannuccilli J D, Cronan J J, Monchik J M. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy.  J Ultrasound Med. 2004;  23 1455-1464
• 60 Mihailovic J, Stefanovic L, Prvulovic M. Magnetic resonance imaging in diagnostic algorithm of solitary cold thyroid nodules.  J BUON. 2006;  11 341-346
• 61 Wang J, Takashima S, Matsushita T, Takayama F, Kobayashi T, Kadoya M. Esophageal invasion by thyroid carcinomas: prediction using magnetic resonance imaging.  J Comput Assist Tomogr. 2003;  27 18-25
• 62 Roychowdhury S, Loevner L A, Yousem D M, Chalian A, Montone K T. MR imaging for predicting neoplastic invasion of the cervical esophagus.  AJNR Am J Neuroradiol. 2000;  21 1681-1687
• 63 Wildi S M, Fickling W E, Day T A. et al . Endoscopic ultrasonography in the diagnosis and staging of neoplasms of the head and neck.  Endoscopy. 2004;  36 624-630
• 64 Magnano M, Bongioannini G, Cirillo S. et al . Virtual endoscopy of laryngeal carcinoma: is it useful?.  Otolaryngol Head Neck Surg. 2005;  132 776-782
• 65 Takashima S, Takayama F, Wang J, Kobayashi S, Kadoya M. Using MR imaging to predict invasion of the recurrent laryngeal nerve by thyroid carcinoma.  AJR Am J Roentgenol. 2003;  180 837-842
• 66 Takashima S, Takayama F, Wang Q, Kawakami S, Saito A, Kobayashi S, Sone S. Differentiated thyroid carcinomas. Prediction of tumor invasion with MR imaging.  Acta Radiol. 2000;  41 377-383
• 67 Schlumberger M, Berg G, Cohen O. et al . Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.  Eur J Endocrinol. 2004;  150 105-112
• 68 Kokemueller H, Swennen G, Brueggemann N, Brachvogel P, Eckardt A, Hausamen J E. Epithelial malignancies of the salivary glands: clinical experience of a single institution - a review.  Int J Oral Maxillofac Surg. 2004;  33 423-432
• 69 Wahlberg P, Anderson H, Biorklund A, Moller T, Perfekt R. Carcinoma of the parotid and submandibular glands - a study of survival in 2465 patients.  Oral Oncol. 2002;  38 706-713
• 70 Callender D L, Frankenthaler R A, Luna M A, Lee S S, Goepfert H. Salivary gland neoplasms in children.  Arch Otolaryngol Head Neck Surg. 1992;  118 472-476
• 71 Pinkston J A, Cole P. Incidence rates of salivary gland tumors: results from a population-based study.  Otolaryngol Head Neck Surg. 1999;  120 834-840
• 72 Divi V, Fatt M A, Teknos T N, Mukherji S K. Use of cross-sectional imaging in predicting surgical location of parotid neoplasms.  J Comput Assist Tomogr. 2005;  29 315-319
• 73 Vander Poorten V, Balm A J, Hilgers F JM. Management of cancer of the parotid gland.  Curr Opin Otolaryngol Head Neck Surg. 2002;  10 134-144
• 74 Shah G V. MR imaging of salivary glands.  Magn Reson Imaging Clin N Am. 2002;  10 631-662
• 75 Harnsberger H R. (Hrsg) .Diagnostic Imaging: Head and Neck. Salt Lake City; Amirsys 2004
• 76 Curtin H D. Detection of perineural spread: fat suppression versus no fat suppression.  AJNR Am J Neuroradiol. 2004;  25 1-3
• 77 Ginsberg L E. MR imaging of perineural tumor spread.  Neuroimaging Clin N Am. 2004;  14 663-677
• 78 Nemzek W R, Hecht S, Gandour-Edwards R, Donald P, McKennan K. Perineural spread of head and neck tumors: how accurate is MR imaging?.  AJNR Am J Neuroradiol. 1998;  19 701-706
• 79 Schmalfuss I M, Tart R P, Mukherji S, Mancuso A A. Perineural tumor spread along the auriculotemporal nerve.  AJNR Am J Neuroradiol. 2002;  23 303-311
• 80 Hamilton B E, Salzman K L, Wiggins III R HH , Harnsberger H R. Earring lesions of the parotid tail.  AJNR Am J Neuroradiol. 2003;  24 1757-1764
• 81 Sakamoto M, Sasano T, Higano S, Takahashi S, Iikubo M, Kakehata S. Usefulness of heavily T(2) weighted magnetic resonance images for the differential diagnosis of parotid tumours.  Dentomaxillofac Radiol. 2003;  32 295-299
• 82 Eida S, Sumi M, Sakihama N, Takahashi H, Nakamura T. Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy.  AJNR Am J Neuroradiol. 2007;  28 116-121
• 83 Weissman J L, Carrau R L. Anterior facial vein and submandibular gland together: predicting the histology of submandibular masses with CT or MR imaging.  Radiology. 1998;  208 441-446
• 84 Loevner L A, Sonners A I. Imaging of neoplasms of the paranasal sinuses.  Magn Reson Imaging Clin N Am. 2002;  10 467-93
• 85 Som P M, Shapiro M D, Biller H F, Sasaki C, Lawson W. Sinonasal tumors and inflammatory tissues: differentiation with MR imaging.  Radiology. 1988;  167 803-8
• 86 Phillips C D, Futterer S F, Lipper M H, Levine P A. Sinonasal undifferentiated carcinoma: CT and MR imaging of an uncommon neoplasm of the nasal cavity.  Radiology. 1997;  202 477-80
• 87 Eisen M D, Yousem D M, Loevner L A, Thaler E R, Bilker W B, Goldberg A N. Preoperative imaging to predict orbital invasion by tumor.  Head Neck. 2000;  22 456-62
• 88 Eisen M D, Yousem D M, Montone K T, Kotapka M J, Bigelow D C, Bilker W B, Loevner L A. Use of preoperative MR to predict dural, perineural, and venous sinus invasion of skull base tumors.  AJNR Am J Neuroradiol. 1996;  17 1937-45
• 89 Hermans R, de Vuysere S, Marchal G. Squamous cell carcinoma of the sinonasal cavities.  Semin Ultrasound CT MR. 1999;  20 150-161
• 90 Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanaret M. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications.  Eur Arch Otorhinolaryngol. 2007;  264 531-538
• 91 Som P M. Lymph nodes of the neck.  Radiology. 1987;  165 593-600
• 92 Som P M, Curtin H D, Mancuso A A. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications.  Arch Otolaryngol Head Neck Surg. 1999;  125 388-396
• 93 Mukherji S K, Armao D, Joshi V M. Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect.  Head Neck. 2001;  23 995-1005
• 94 Ferlito A, Som P M, Rinaldo A, Mondin V. Classification and terminology of neck dissections.  ORL J Otorhinolaryngol Relat Spec. 2000;  62 212-216
• 95 Friedman M, Mafee M F, Pacella Jr B L , Strorigl T L, Dew L L, Toriumi D M. Rationale for elective neck dissection in 1990.  Laryngoscope. 1990;  100 54-94
• 96 Mancuso A A, Harnsberger H R, Muraki A S, Stevens M H. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging head and neck cancer. Part II: pathology.  Radiology. 1983;  148 715-723
• 97 Som P M. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis.  AJR Am J Roentgenol. 1992;  158 961-969
• 98 Stern W B, Silver C E, Zeifer B A, Persky M S, Heller K S. Computed tomography of the clinically negative neck.  Head Neck. 1990;  12 109-113
• 99 Bruneton J N, Balu-Maestro C, Marcy P Y, Melia P, Mourou M Y. Very high frequency (13 MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules.  J Ultrasound Med. 1994;  13 87-90
• 100 Steinkamp H J, Hosten N, Richter C, Schedel H, Felix R. Enlarged cervical lymph nodes at helical CT.  Radiology. 1994;  191 795-798
• 101 van den Brekel M W, Stel H V, Castelijns J A, Nauta J J, van der Waal I, Valk J, Meyer C J, Snow G B. Cervical lymph node metastasis: assessment of radiologic criteria.  Radiology. 1990;  177 379-384
• 102 Steinkamp H J, Cornehl M, Hosten N, Pegios W, Vogl T, Felix R. Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy.  Br J Radiol. 1995;  68 266-270
• 103 Close L G, Merkel M, Vuitch M F, Reisch J, Schaefer S D. Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx.  Head Neck. 1989;  11 309-317
• 104 Vassallo P, Wernecke K, Roos N, Peters P E. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US.  Radiology. 1992;  183 215-220
• 105 Saleh A. Cervical lymph nodes and thyroid. In: Hofer M (Hrsg) Teaching manual of color duplex sonography. Stuttgart; Thieme 2004: 27-29
• 106 Curtin H D, Ishwaran H, Mancuso A A, Dalley R W, Caudry D J, McNeil B J. Comparison of CT and MR imaging in staging of neck metastases.  Radiology. 1998;  207 123-130
• 107 van den Brekel M W. Lymph node metastases: CT and MRI.  Eur J Radiol. 2000;  33 230-238
• 108 Don D M, Anzai Y, Lufkin R B, Fu Y S, Calcaterra T C. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck.  Laryngoscope. 1995;  105 669-674
• 109 Friedman M, Roberts N, Kirshenbaum G L, Colombo J. Nodal size of metastatic squamous cell carcinoma of the neck.  Laryngoscope. 1993;  103 854-856
• 110 Chong V F, Fan Y F, Khoo J B. MRI features of cervical nodal necrosis in metastatic disease.  Clin Radiol. 1996;  51 103-109
• 111 van den Brekel M W, Castelijns J A, Stel H V. et al . Detection and characterization of metastatic cervical adenopathy by MR imaging: comparison of different MR techniques.  J Comput Assist Tomogr. 1990;  14 581-589
• 112 Yousem D M, Som P M, Hackney D B, Schwaibold F, Hendrix R A. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT.  Radiology. 1992;  182 753-759
• 113 Anzai Y, Blackwell K E, Hirschowitz S L. et al . Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.  Radiology. 1994;  192 709-15
• 114 Anzai Y, Piccoli C W, Outwater E K. et al . Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.  Radiology. 2003;  228 777-788
• 115 Baghi M, Mack M G, Hambek M, Rieger J, Vogl T, Gstoettner W, Knecht R. The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers.  Anticancer Res. 2005;  25 3665-3670
• 116 Hoffman H T, Quets J, Toshiaki T. et al . Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy.  Laryngoscope. 2000;  110 1425-1430
• 117 Mack M G, Balzer J O, Straub R, Eichler K, Vogl T J. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.  Radiology. 2002;  222 239-244
• 118 Saleh A, Jonkmanns C, Rees M, Ballo H, Jonkmanns C, Mödder U. Ultrasmall superparamagnetic iron oxide enhanced MR imaging in patients with head and neck cancer.  Radiology. 2002;  225[Suppl] 724
• 119 Sigal R, Vogl T, Casselman J. et al . Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial.  Eur Radiol. 2002;  12 1104-1113
• 120 Ferlito A, Rinaldo A, Buckley J G, Mondin V. General considerations on distant metastases from head and neck cancer.  ORL J Otorhinolaryngol Relat Spec. 2001;  63 189-191
• 121 Brouwer J, Bree R, Hoekstra O S, Langendijk J A, Castelijns J A, Leemans C R. Screening for distant metastases in patients with head and neck cancer: what is the current clinical practice?.  Clin Otolaryngol. 2005;  30 438-443
• 122 Ferlito A, Buckley J G, Rinaldo A, Mondin V. Screening tests to evaluate distant metastases in head and neck cancer.  ORL J Otorhinolaryngol Relat Spec. 2001;  63 208-211
• 123 Tesche S, Habermann C R, Sagowski C, Wenzel S, Metternich F U. The value of chest CT-scanning for staging of progressed or recurrent head and neck squamous cell carcinomas (HNSCC).  Laryngorhinootologie. 2006;  85 93-98
• 124 Brouwer J, de Bree R, Hoekstra O S, Golding R P, Langendijk J A, Castelijns J A, Leemans C R. Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient?.  Laryngoscope. 2005;  115 1813-1817
• 125 Quint L E, Park C H, Iannettoni M D. Solitary pulmonary nodules in patients with extrapulmonary neoplasms.  Radiology. 2000;  217 257-261
• 126 Brouwer J, Senft A, de Bree R, Comans E F, Golding R P, Castelijns J A, Hoekstra O S, Leemans C R. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?.  Oral Oncol. 2006;  42 275-280
• 127 Yen R F, Hong R L, Tzen K Y, Pan M H, Chen T H. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.  J Nucl Med. 2005;  46 770-774
• 128 Yen T C, Chang J T, Ng S H. et al . The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.  J Nucl Med. 2005;  46 405-410